HPS2-THRIVE: Game (Mostly) Over for Niacin (CME/CE)

(MedPage Today) -- Publication of landmark trial results affirmed no benefit and worrisome adverse events from adding extended-release niacin to statin therapy, but many physicians weren't ready to concede failure of the purported HDL mechanism.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news